How has been the historical performance of Natural Biocon?
2025-11-19 22:45:59Answer: The historical performance of Natural Biocon shows a fluctuating trend in its financial metrics over the years. Breakdown: Natural Biocon's net sales have seen significant growth from Mar'20, where it reported no sales, to Mar'25 with sales of 8.35 Cr, although this is a decline from the previous year's sales of 13.53 Cr. The total operating income followed a similar pattern, increasing from 0.00 Cr in Mar'20 to 8.35 Cr in Mar'25, but also down from 13.53 Cr in Mar'24. The company's total expenditure, excluding depreciation, rose from 0.03 Cr in Mar'20 to 8.29 Cr in Mar'25, reflecting increased operational costs. Operating profit (PBDIT) peaked at 0.24 Cr in Mar'23 but fell to 0.06 Cr in Mar'25. Profit before tax also decreased from 0.25 Cr in Mar'23 to 0.06 Cr in Mar'25, while profit after tax dropped to 0.04 Cr in Mar'25 from 0.15 Cr in Mar'24. The company's equity capital increased significantly...
Read MoreHow has been the historical performance of Natural Biocon?
2025-11-13 00:35:38Answer: The historical performance of Natural Biocon shows a fluctuating trend in its financial metrics over the years. Breakdown: Natural Biocon's net sales have seen significant growth from Mar'20, where it recorded no sales, to Mar'25 with sales of 8.35 Cr, although it peaked at 13.53 Cr in Mar'24. The total operating income followed a similar trajectory, increasing from 0.00 Cr in Mar'20 to 8.35 Cr in Mar'25. However, total expenditure also rose, reaching 8.29 Cr in Mar'25 from just 0.03 Cr in Mar'20. Operating profit, while positive in recent years, has declined from 0.24 Cr in Mar'23 to 0.06 Cr in Mar'25. Profit after tax has also decreased from 0.18 Cr in Mar'23 to 0.04 Cr in Mar'25. The company's total assets increased significantly from 12.71 Cr in Mar'20 to 38.52 Cr in Mar'25, driven by a rise in non-current investments to 21.12 Cr in Mar'25. Total liabilities also grew, reaching 38.52 Cr in Mar'...
Read MoreResults-Delay in Financial Results
01-Dec-2025 | Source : BSERevised Financial Result for the quarter ended September 30 2025.
Outcome Of The Meeting Of The Board Of Directors Held On Friday November 14 2025.
19-Nov-2025 | Source : BSEAs attached.
Results-Delay in Financial Results
19-Nov-2025 | Source : BSEOutcome of the meeting of board of directors held on Friday November 14 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






